AGT and cardiac hypertrophy: The same study reported that treatment with low-dose bortezomib (50 μg/kg, i.p.)three times per week for a period of 14 days reduced angiotensin II (1.4 mg/kg/day)-mediated cardiac hypertrophy and fibrosis (48).